UBS Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
MIP
UBS Group's SNY Position: Q1 2026 in Review
UBS Group reduced its Sanofi (SNY) stake by 19% in Q1 2026, selling an estimated $11.1M and leaving 983,846 shares worth $47.4M. The position accounts for 0.01% of the portfolio, ranked #1701.
UBS Group first reported a position in SNY in Q4 2014 and has held it in 46 quarters since. The position peaked at $89M in Q1 2015. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- UBS Group held 983,846 shares of Sanofi worth $47.4M as of Q1 2026.
- UBS Group sold 238,157 Sanofi shares in Q1 2026, an estimated $11.1M.
- Sanofi made up 0.01% of UBS Group's portfolio in Q1 2026, its #1701 holding.
- UBS Group first reported a position in Sanofi in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Sanofi position peaked at $89M in Q1 2015.
- 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.